fashion -WSS

fashion

author：fashion 2025-10-01 18:45:43 - browse：93327

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

This week: A chat with Argenx CEO Tim Van Hauwermeiren, and updates on biotech PIPEs, Madrigal Pharmaceuticals, and Annovis Bio.

The Belgian drugmaker Argenx is preparing for a commercial launch this summer that will expand the use of its IgG-lowering antibody Vyvgart to patients with chronic inflammatory demyelinating polyneuropathy, or CIDP, an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections
Next article： Carvykti CAR

hotspot

explore

WSS

Medicare Advantage beneficiaries sue Humana over algorithm use

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Hospitals owned by private equity see complications spike 25%

Virtual care provider acquires bankrupt Pear's prescription apps

Prime Medicine, Myeloid Therapeutics clash over genome

ALS groups 'won't be played again' by the FDA, drug sponsors

focus

fashion

hotspot

The high cost of giving birth even with insurance

Hospitals owned by private equity see complications spike 25%

How one medical school became remarkably diverse

Christmas in the PICU brings some surprising joy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Christmas in the PICU brings some surprising joy

Malaria cases in Florida and Texas: Here’s what you need to know

Flu vaccine offering decent levels of protection this winter, new data show

The cancer drug shortage isn’t new — and neither are the solutions

In Spain, a hospital brews its own CAR

Wikipedia

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

RaDonda Vaught to speak at CommonSpirit event on patient safety

Editas, Vertex strike deal on CRISPR

What STAT readers think about the FDA and patient advocacy

hotspot

explore

explore

explore